United Therapeutics Corp (UTHR)

12:18 PM

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for Pulmonary Fibrosis - TipRanks

12:18 PM

08:19 AM

United Therapeutics stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com Canada

08:19 AM

Aug 13, 2025

United Therapeutics stock price target raised to $415 from $385 at UBS - Investing.com

Aug 13, 2025

Aug 13, 2025

United Therapeutics stock price target raised to $415 from $385 at UBS By Investing.com - Investing.com South Africa

Aug 13, 2025

Aug 12, 2025

United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

Aug 12, 2025

Aug 09, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: A Potential Game-Changer - The Globe and Mail

Aug 09, 2025

Aug 08, 2025

Pfizer’s Inclacumab Study: Long-term Safety Insights for Sickle Cell Disease - The Globe and Mail

Aug 08, 2025

Aug 08, 2025

Should You Be Adding United Therapeutics (NASDAQ:UTHR) To Your Watchlist Today? - 富途牛牛

Aug 08, 2025

Aug 07, 2025

United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment - TipRanks

Aug 07, 2025

Aug 06, 2025

MannKind (MNKD) Q2 Revenue Rises 6% - The Motley Fool

Aug 06, 2025

Aug 04, 2025

H.C. Wainwright Lowers PT on United Therapeutics Corporation (UTHR) to $400 From $425, Keeps a Buy Rating - Insider Monkey

Aug 04, 2025

Aug 01, 2025

United Therapeutics Announces $1B Accelerated Share Repurchase Program. - AInvest

Aug 01, 2025

Aug 01, 2025

United Therapeutics Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance

Aug 01, 2025

Aug 01, 2025

United Therapeutics’ PAH Study Update: Implications for Investors - TipRanks

Aug 01, 2025

Aug 01, 2025

United Therapeutics Advances in Pulmonary Fibrosis Treatment with Phase 3 Study - TipRanks

Aug 01, 2025

Aug 01, 2025

United Therapeutics (UTHR) Launches $1B Stock Buyback Program - GuruFocus

Aug 01, 2025

Aug 01, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 01, 2025

Aug 01, 2025

United Therapeutics stock jumps on $1 billion share repurchase plan - Investing.com

Aug 01, 2025

Aug 01, 2025

United Therapeutics Launches $1 Bln Stock Buyback - Nasdaq

Aug 01, 2025

Aug 01, 2025

United Therapeutics Unveils Massive $1B Stock Buyback Plan in Strategic Financial Move - Stock Titan

Aug 01, 2025

Aug 01, 2025

Pulmonary Arterial Hypertension Drug Market to See Booming - openPR.com

Aug 01, 2025

Aug 01, 2025

What is the dividend policy of United Therapeutics Corporation stockFree Stock Alerts For Every Investor - Jammu Links News

Aug 01, 2025

Aug 01, 2025

United Therapeutics Reports Record Q2 2025 Financial Results - The Globe and Mail

Aug 01, 2025

Jul 31, 2025

BTIG Lowers Liquidia (LQDA) PT to $40, Potential for Yutrepia Launch Remains a Focus - Insider Monkey

Jul 31, 2025

Jul 31, 2025

United Therapeutics Reports Record Revenue and Growth - TipRanks

Jul 31, 2025

Jul 31, 2025

United Therapeutics (UTHR) Price Target Lowered by HC Wainwright & Co. | UTHR Stock News - GuruFocus

Jul 31, 2025

Jul 31, 2025

H.C. Wainwright lowers United Therapeutics stock price target on Tyvaso competition concerns - Investing.com Nigeria

Jul 31, 2025

Jul 31, 2025

United Therapeutics Corp (UTHR) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada

Jul 31, 2025

Jul 31, 2025

United Therapeutics: Q2 Earnings Snapshot - Greenwich Time

Jul 31, 2025

Jul 31, 2025

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight - GuruFocus

Jul 31, 2025

Jul 30, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for IPF Treatment - TipRanks

Jul 30, 2025

Jul 30, 2025

United Therapeutics Stock Slides On Q2 Earnings: The Details - 富途牛牛

Jul 30, 2025

Jul 30, 2025

Earnings call transcript: United Therapeutics Q2 2025 misses EPS, stock drops - Investing.com Canada

Jul 30, 2025

Jul 30, 2025

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance

Jul 30, 2025

Jul 30, 2025

Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics - Nasdaq

Jul 30, 2025

Jul 30, 2025

United Therapeutics Q2 2025 slides: Revenue up 12% as Tyvaso drives growth - Investing.com Nigeria

Jul 30, 2025

Jul 30, 2025

United Therapeutics Logs Growth And Launches Big Buyback - Finimize

Jul 30, 2025

Jul 30, 2025

United Therapeutics (UTHR) Misses Q2 Earnings Estimates - Yahoo Finance

Jul 30, 2025

Jul 30, 2025

United Therapeutics misses Q2 earnings expectations By Investing.com - Investing.com South Africa

Jul 30, 2025

Jul 30, 2025

United Therapeutics misses Q2 earnings expectations - Investing.com

Jul 30, 2025

Jul 30, 2025

United Therapeutics (NASDAQ:UTHR) Misses Q2 Revenue Estimates - Yahoo Finance

Jul 30, 2025